NEUROBLOC

This brand name is authorized in Austria, Cyprus, Estonia, Finland, France, Ireland, Lithuania, Poland, Romania, Spain.

Active ingredients

The drug NEUROBLOC contains one active pharmaceutical ingredient (API):

1	Botulinum toxin type B UNII 0Y70779M1F - RIMABOTULINUMTOXINB
	Botulinum toxin type B is a neuromuscular blocking agent indicated for the treatment of cervical dystonia. When injected directly into a muscle, it causes a localised paralysis that gradually reverses over time.
	Read more about Botulinum toxin type B

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NEUROBLOC Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M03AX01	Botulinum toxin	M Musculo-skeletal system → M03 Muscle relaxants → M03A Muscle relaxants, peripherally acting agents → M03AX Other muscle relaxants, peripherally acting agents
Discover more medicines within M03AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1197918, 1197929, 1197930
ES	Centro de información online de medicamentos de la AEMPS	01166001, 01166002, 01166003
FI	Lääkealan turvallisuus- ja kehittämiskeskus	117394, 165814, 396454
FR	Base de données publique des médicaments	63181966
LT	Valstybinė vaistų kontrolės tarnyba	1029581, 1029582, 1029583
PL	Rejestru Produktów Leczniczych	100312009
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W51605001, W51605002, W51605003